Institut Paoli-Calmettes Marseille

Marseille 13273

0 studies enrolling now · 3 studies all time

What they study most

Blastic Plasmacytoid Dendritic Cell Neoplasm, Carcinoma, Transitional Cell, Myeloproliferative Neoplasm, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN — Running, not enrolling
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed